BAP Consensus Guidelines

Document Title Size Published
Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the British Association for Psychopharmacology
Topic: Adult ADHD
Co-Authors: Blanca Bolea-Alamañac, David J Nutt, Marios Adamou, Phillip Asherson, Stephen Bazire, David Coghill, David Heal, Ulrich Müller, John Nash, Paramalah Santosh, Kapil Sayal, Edmund Sonuga- Barke and Susan J Young for the Consensus Group
Show: full details
397 Kb 2014
Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology
Topic: Anxiety Disorder
Co-Authors: David S Baldwin, Ian M Anderson, David J Nutt, Christer Allgulander, Borwin Bandelow, Johan A den Boer, David M Christmas, Simon Davies, Naomi Fineberg, Nicky Lidbetter, Andrea Malizia, Paul McCrone, Daniel Nabarro, Catherine O’Neill, Jan Scott, Nic van der Wee and Hans-Ulrich Wittchen
Show: full details
683 Kb 2014
Benzodiazepines: Risks and benefits. A reconsideration
Topic: Benzodiazepines
Co-Authors: David S Baldwin, Katherine Aitchison, Alan Bateson, H Valerie Curran, Simon Davies, Brian Leonard, David J Nutt, David N Stephens and Sue Wilson
Show: full details
726 Kb 2013
Evidence based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from the British Association for Psychopharmacology
Topic: Addiction
Co-Authors: AR Lingford-Hughes, S Welch, L Peters and DJ Nutt
Show: full details
1,134 Kb 2012
British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders
Topic: Insomnia
Co-Authors: SJ Wilson, DJ Nutt, C Alford, SV Argyropoulos, DS Baldwin, AN Bateson, TC Britton, C Crowe, D-J Dijk, CA Espie, P Gringras, G Hajak, C Idzikowski, AD Krystal, JR Nash, H Selsick, AL Sharpley and AG Wade
Show: full details
752 Kb 2010
Clinical practice with anti-dementia drugs: a revised (second) consensus statement from British Association for Psychopharmacology
Topic: Anti-Dementia Drugs
Co-Authors: A Burns and J O’Brien on behalf of the BAP Dementia Consensus Group
Show: full details
466 Kb 2010
Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology
Topic: Schizophrenia
Co-Authors: Thomas R E Barnes and the Consensus Group
Show: full details
422 Kb 2010
Evidence-based Guidelines for Treating Bipolar Disorder
Topic: Bipolar Disorder
Co-Authors: GM Goodwin on behalf of the Consensus Group
Show: full details
645 Kb 2009
Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines
Topic: Antidepressants
Co-Authors: IM Anderson, IN Ferrier, RC Baldwin, PJ Cowen, L Howard, G Lewis, K Matthews, RH McAllister-Williams, RC Peveler, J Scott, A Tylee
Show: full details
491 Kb 2008

Latest News

Subscribe to the News Feed rss feed

  1. BAP at Cheltenham Science Festival
    on 3rd April 2014

    Ciara McCabe will be speaking at this year's Cheltenham Science Festival, discussing 'Food on the Brain' with Phil Burnet
    Event Details
  2. Anxiety Guidelines Updated
    on 31st March 2014

    Updated BAP Guidelines for the pharmacological treatment of Anxiety Disorders are now available for download
    Download Guidelines
  3. ADHD Guidelines Updated
    on 18th February 2014

    Updated BAP Guidelines for the pharmacological management of ADHD are now available for download
    Download Guidelines

See more news